Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Speak Out Rheum: How Did We Go So Wrong with Opioid Prescribing?

Richard Brasington Jr., MD, FACP, MACR  |  Issue: November 2022  |  November 4, 2022

A third major problem has been the lack of understanding of addiction and which persons have the greatest risk of developing addiction.

Dependence vs. Addiction

Opioid dependence develops when patients have clinical withdrawal as the dose is reduced or withheld. This is distinct from addiction, which is the compulsive, harmful, sometimes illegal use of a chemical substance.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A common misconception exists that anyone can become addicted by taking opioids. It is true that patients taking opioids for over three months do have an increased risk of developing addiction.10 Observational studies show that “of patients who receive a single opioid prescription in the emergency department, after surgery or at the dentist’s office, 1% to 6% end up using opioids for at least 12 months or being diagnosed with opioid use disorder.”11

The potential to develop addiction is neurochemical. Addiction develops when the limbic system (or the lizard brain) hijacks the brains frontal lobe. In the case of opioids (or alcohol, or other substances), the lizard brain derives such intense pleasure from the opioid stimulation that it demands more input, overriding the frontal lobe’s restraint. This is not a conscious act: the primitive brain takes over, and opioid use becomes compulsive and unrestrained.12

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

A prevailing assumption is that taking prescription opioids leads to heroin addiction. An analysis by the National Institute on Drug Abuse, National Institutes of Health and the FDA notes, “Available data indicate that the nonmedical [emphasis mine] use of prescription opioids is a strong risk factor for heroin use”; however, “heroin use among people who use prescription opioids for medical reasons is rare, and the transition to heroin use appears to occur at a low rate.”13

I do not make this point to excuse those with chemical dependency. We are all ultimately responsible for our actions, and if an addicted individual develops insight into their problem, it requires hard work and making good decisions to recover. The point is that only a minority of people are preprogrammed to develop addiction.20,21 It is often stated that many individuals who become addicted to illicit drugs start with prescription drugs, but it does not logically follow that all persons who take prescription opioids are at risk of becoming addicted.

So how does one know in advance that a patient is prone to develop addiction, that their brains are primed for addiction? Some situations are obvious, but in many cases it is not possible to know in advance, and therein lies the dilemma for the prescribing physician. One solution is to have, at the outset, a pain contract, which stipulates the rules for receiving opioids (or other controlled medications), and the understanding that violating the contract means the end of more prescribing. (In my experience, second chances have a very predictable negative outcome.)

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:AnalgesicsDrug UpdatesOpinionSpeak Out Rheum Tagged with:opioid crisisPain Syndrome FocusRheumSpeak Out Rheumatology

Related Articles
    ah_designs / shutterstock.com

    The Perils of Pain Meds Revisited

    December 18, 2018

    More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

    Rheumatologists Respond to Prescription Opioid Analgesic Crisis

    May 16, 2017

    The alarming statistics on prescription opioid overdoses are well known to medical professionals, thanks to the Centers for Disease Control and Prevention (CDC)’s widely cited finding that deaths from opioid analgesics have increased fourfold since 1999.1 Half of all fatal drug overdoses now involve opioids prescribed by a doctor. Meanwhile, a lack of rigorous research…

    10 Tips for Opioid Prescribing

    December 1, 2014

    How to manage the risks when prescribing medications for patients in chronic pain

    Beyond Addiction: Medical Therapy for Addiction May Benefit Medical Adherence

    June 17, 2019

    Treating patients with rheumatic disease for their addictions will also encourage patients to address their overall health conditions, resulting in better medical adherence…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences